Lena Biosciences

About:

Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapy testing.

Website: http://www.lenabio.com/

Twitter/X: lenabiosciences

Top Investors: National Science Foundation, National Institute of Neurological Disorders and Stroke, ATDC, NCATS, National Institute of Environmental Health Sciences

Description:

Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapies, biomedical research and drug testing. Its new PerfusionPal product is a high-throughput organ-on-a-chip insert system that yields up to 5 times greater drug metabolism. It fits into existing workflows and enables customers to emulate multiple organs, deliver and test drugs in a standard format for ADME Tox screening, cancer research, and precision therapies. Owing to concentrated secretome and metabolome, PerfusionPal is ideally suited for testing slow-to-metabolize drugs and biologics (monoclonal antibodies and antibody-drug conjugates).